Tango Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Tango Therapeutics, Inc. (TNGX) reported Earnings Per Share, Basic and Diluted of -$0.29 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-11
- Tango Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.29.
- Tango Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.28.
- Tango Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was $0.00.
- Tango Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.29.
- Tango Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.94.
- Tango Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.63.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 4 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 7 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.29 10-Q · filed 2022-05-11 | ||||||
| 2021-12-31 | -$0.94 10-K · filed 2022-03-28 | ||||||
| 2021-09-30 | -$0.28 10-Q · filed 2021-11-09 | -$0.68 10-Q · filed 2021-11-09 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | |||||
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-11 | $0.00 10-Q · filed 2021-05-14 | |||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-31 | -$1.63 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | -$0.76 10-Q · filed 2021-11-09 | $0.00 10-Q · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | -$1.48 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |